EHI
ALKS icon

Eagle Health Investments’s Alkermes ALKS Stock Holding History

Eagle Health Investments’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.6M Buy
297,302
+58,629
+25% +$2.29M 2.58% 17
2026
Q1 		$8.44M Buy
238,673
+156,873
+192% +$4.87M 1.48% 23
2025
Q4 		$2.29M Hold
81,800
– – 0.5% 27
2025
Q3 		$2.45M Buy
+81,800
New +$2.31M 0.64% 20

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Eagle Health Investments's ALKS Position: Q2 2026 in Review

Eagle Health Investments increased its Alkermes (ALKS) stake by 25% in Q2 2026, buying an estimated $2.29M and bringing the position to 297,302 shares worth $15.6M. The position accounts for 2.58% of the portfolio, ranked #17.

Eagle Health Investments first reported a position in ALKS in Q3 2025 and has held it in 4 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Eagle Health Investments held 297,302 shares of Alkermes worth $15.6M as of Q2 2026.
  • Eagle Health Investments bought 58,629 Alkermes shares in Q2 2026, an estimated $2.29M.
  • Alkermes made up 2.58% of Eagle Health Investments's portfolio in Q2 2026, its #17 holding.
  • Eagle Health Investments first reported a position in Alkermes in Q3 2025 and has held it in 4 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.